One of the main symptoms of Parkinson’s
disease is a deterioration of motor functions, which can be grouped into
four different categories: tremor, rigidity, slowness of movement and
postural instability. Tremors are certainly the most visible and
well-known of the motor symptoms, but there are numerous other specific
motor symptoms that patients can suffer from, depending on the
individual.
Please view the interview: https://www.youtube.com/watch?v=En5HJBxstVk
In addition to the motor symptoms, there are also neuropsychiatric
symptoms of Parkinson’s disease that can include a deterioration of
certain cognitive functions, mood disorders or behavioural disorders.
These disorders largely manifest themselves as problems with
concentration, memory, language and visuospatial skills. The progressive
deterioration of this cognitive capacity can, over the long-term,
result in a much more severe manifestation of dementia.
Since the 1970s, the scientific community
– prompted by frequent reports from patients opting for self-medication
– has been able to focus its research on cannabinoids for the treatment
of Parkinson’s disease. The number of studies conducted on the subject
continues to be relatively low, despite recent renewed efforts in this
direction owing to the frequency of cases reported by patients suffering
from the disease.
Tests were carried out on patients with
an average age of 66 and were conducted before consuming cannabis, then
30 minutes after consuming cannabis. The differences in the scores
obtained on each of the key motor symptoms were conclusive, especially
insofar as these patients had been diagnosed on average 7.5 years
previously.
The patients tested had a common variable: they were all regular consumers of cannabis, having opted of their own accord for self-medication. According to these patients, one “dose” of cannabis, i.e. one cannabis cigarette or one dose of vaporised cannabis, could provide relief for 2 to 3 hours.
Finally, an observational study presented by Israeli neuroscientists in March 2014
proved for the first time the efficacy of cannabinoids on a group of
symptoms of Parkinson’s disease, including both motor and non-motor
disorders. These findings represent incredible progress as these types
of tests have always been difficult, or near impossible, because of the
limited availability of medicinal cannabis for use in research.
Continue reading: http://sensiseeds.com/en/blog/cannabis-parkinsons-disease/
No comments:
Post a Comment